NeuroBo Pharmaceuticals Profit Margin 1970-1969 | MTVA
Current and historical gross margin, operating margin and net profit margin for NeuroBo Pharmaceuticals (MTVA) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. NeuroBo Pharmaceuticals net profit margin as of December 31, 1969 is 0%.
| NeuroBo Pharmaceuticals Annual Profit Margins |
| NeuroBo Pharmaceuticals Quarterly Profit Margins |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$0.022B |
$0.000B |
|
NeuroBo Pharmaceuticals Inc. is a biopharmaceutical company. It is focused on novel treatments for neurodegenerative diseases. The company's novel lead candidate NB-01 is a drug candidate for diabetic neuropathic pain. NB-02 focuses on the treatment of neurodegenerative diseases. NeuroBo Pharmaceuticals Inc., formerly known as Gemphire Therapeutics Inc., is based in Northville, United States.
|
